Julia Schoelermann

Julia Schoelermann is currently the Vice President of Corporate Development at 35Pharma. Julia previously held roles such as Director of Translational Science at HyperMabs Inc. and Director of Business Development & Investor Relations at Forbius. Additionally, Julia has experience in various research and project management roles at universities and holds a Doctor of Philosophy degree in Biomedicine from the University of Bergen. Schoelermann also holds a Master of Business Administration degree from Brown University and IE Business School.